Hikma Pharmaceutical | HIK - Ordinary Share Capital


Hikma Pharmaceutical reported $221.89M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Almirall EUR 214.79M 0 Dec/2025
argenx SE USD 62.54M 2.74M Jun/2026
AstraZeneca USD 1.55B 44K Jun/2026
Autolus Therapeutics Ltd USD 266.14M 0 Mar/2026
Bayer EUR 982.42M 0 Mar/2026
Fresenius EUR 563.24M 0 Dec/2025
Genmab DKK 61.62M 52K Dec/2025
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
GRIFOLS EUR 680.58M 6K Jun/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lakefront Biotherapeutics EUR 65.9M 0 Mar/2026
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Mar/2026
Orion EUR 140.87M 0 Jun/2026
Recordati EUR 204.81M 1.38M Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
UCB EUR 190.36M 365.15K Dec/2025